|
Volumn 44, Issue 7, 2004, Pages 1363-1367
|
Actinomycin-eluting stent for coronary revascularization: A randomized feasibility and safety study: The ACTION trial
a b a c d e a f g h f i j k l m n o p q more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOPIDOGREL;
DACTINOMYCIN;
PACLITAXEL;
RAPAMYCIN;
ADULT;
AGED;
ANGIOGRAPHY;
ARTERY INTIMA PROLIFERATION;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DEATH;
DISEASE EXACERBATION;
DRUG COATING;
DRUG ELUTING STENT;
DRUG INDUCED DISEASE;
FOLLOW UP;
HEART INFARCTION;
HEART INJURY;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
HYPERPLASIA;
INTRAVASCULAR ULTRASOUND;
MAJOR CLINICAL STUDY;
MALE;
METAL IMPLANTATION;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
SIDE EFFECT;
UNITED STATES;
AGED;
CORONARY ANGIOGRAPHY;
CORONARY ARTERIOSCLEROSIS;
CORONARY RESTENOSIS;
CORONARY VESSELS;
DACTINOMYCIN;
DEATH, SUDDEN, CARDIAC;
DRUG ADMINISTRATION SCHEDULE;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
MYOCARDIAL REVASCULARIZATION;
PROSPECTIVE STUDIES;
SELECTION BIAS;
SINGLE-BLIND METHOD;
STENTS;
TIME FACTORS;
TREATMENT OUTCOME;
TUNICA INTIMA;
ULTRASONOGRAPHY, INTERVENTIONAL;
|
EID: 4644316176
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jacc.2004.03.084 Document Type: Article |
Times cited : (73)
|
References (6)
|